BMI variation increases recurrence risk in women with early-stage breast cancer

Future Oncology

Volumn 10, Issue 15, 2014, Pages 2459-2468

  Fedele, Palma ^a   Orlando, Laura ^a   Schiavone, Paola ^a   Quaranta, Annamaria ^a   Lapolla, Assunta Maria ^a   De Pasquale, Maria ^a   Ardizzone, Antonino ^b   Bria, Emilio ^c   Sperduti, Isabella ^d   Calvani, Nicola ^a   Marino, Antonella ^a   Caliolo, Chiara ^a   Mazzoni, Enrica ^a   Cinieri, Saverio ^a,e  

^a 'A Perrino' Hospital   (Italy)

^b ASL BR 1   (Italy)

^c UNIVERSITY HOSPITAL OF VERONA   (Italy)

^d REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^e EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

BMI; early stage breast cancer; recurrence; weight gain; weight loss

Indexed keywords

ANTHRACYCLINE; AROMATASE INHIBITOR; CAPECITABINE; CYCLOPHOSPHAMIDE; FLUOROURACIL; GONADORELIN ANTAGONIST; METHOTREXATE; TAMOXIFEN; TAXANE DERIVATIVE; TRASTUZUMAB;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; BREAST CANCER; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; EARLY CANCER; FEMALE; HUMAN; HUMAN TISSUE; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; OBESITY; OUTCOME ASSESSMENT; RECURRENCE RISK; RISK ASSESSMENT; WEIGHT GAIN;

EID: 84920023778     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/fon.14.180     Document Type: Article

References (34)

1. Ewertz M, Jensen MB., Gunnarsdottir K et al. Effect of obesity on prognosis after early-stage breast cancer. J. Clin. Oncol. 28, 25-31 (2011).
2. Protani M, Coory M, Martin JH. Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res. Treat. 123, 627-635 (2010).
3. Bastarrachea J, Hortobagyi GN, Smith TL et al. Obesity as an adverse prognostic factor for patients receiving adjuvant chemotherapy for breast cancer. Ann. Intern. Med. 120, 18-25 (1994).
4. De Azambuja E, McCaskill-Stevens W, Francis P et al. The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial. Breast Cancer Res. Treat. 119, 145-153 (2010).
5. Zhang S, Folsom AR, Sellers TA et al. Better breast cancer survival for postmenopausal women who are less overweight and eat less fat: the Iowa Women's Health Study. Cancer 76, 275-283 (1995).
6. Sparano JA, Wang M, Zhao F et al. Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast cancer. Cancer 118, 5937-5946 (2012).
7. Mazzarella L, Disalvatore D, Bagnardi V et al. Obesity increases the incidence of distant metastases in oestrogen receptor-negative human epidermal growth factor receptor 2-positive breast cancer patients. Eur. J. Cancer 49, 3588-3597 (2013).
8. Camoriano JK, Loprinzi CL, Ingle JN et al. Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer. J. Clin. Oncol. 8, 1327-1334. (1990).
9. Kroenke CH, Chen WY, Rosner B et al. Weight, weight gain, and survival after breast cancer diagnosis. J. Clin. Oncol. 23, 1370-1378 (2005).
10. Chen X, Lu W, Zheng W et al. Obesity and weight change in relation to breast cancer survival. Breast Cancer Res. Treat. 3, 823-833 (2010).
11. Heasman KZ, Sutherland HJ, Campbell JA et al. Weight gain during adjuvant chemotherapy for breast cancer. Breast Cancer Res. Treat. 5, 195-200 (1985).
12. Caan BJ, Emond JA, Natarajan L et al. Post diagnosis weight gain and breast cancer recurrence in women with early stage breast cancer. Breast Cancer Res. Treat. 99, 47-57 (2006).
13. Levine EG, Raczynski JM, Carpenter JT. Weight gain with breast cancer adjuvant treatment. Cancer 67, 1954-1959 (1991).
14. Chlebowski R, Blackburn G, Elashoff RM et al. Mature analysis from the Women's Intervention Nutrition Study (WINS) evaluating dietary fat reduction and breast cancer outcome. Breast Cancer Res. Treat. 100, S16 (2006).
15. Pierce J, Natarajan L, Caan B et al. Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) randomized trial. JAMA 298, 289-298 (2007).
16. Caan BJ, Kwan ML, Hartzell G et al. Pre-diagnosis body mass index, post-diagnosis weight change, and prognosis among women with early stage breast cancer. Cancer Causes Control 19, 1319-1328 (2008).
17. Hammond ME, Hayes DF, Dowsett M et al. American Society of Clinical Oncology/ College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J. Clin. Oncol. 28, 2784-2795 (2010).
18. Goldhirsch A, Wood WC, Coates AS et al. Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann. Oncol. 22, 1736-1747 (2011).
19. WHO. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ. Tech. Rep. Ser. 854, 1-452 (1995).
20. WHO. Obesity: preventing and managing the global epidemic. Report on a WHO Consultation on Obesity. World Health Organ Tech. Rep. Ser. 894, 1-253. (2000).
21. Foltz AT. Weight gain among stage II breast cancer patients: a study of five factors. Oncol. Nurs. Forum 12, 21-26 (1985).
22. Perez E. Safety profiles of tamoxifen and the aromatase inhibitors in adjuvant therapy of hormone responsive early breast cancer. Ann. Oncol. 18, 26-35 (2007).
23. Khandekar MJ, Cohen P, Spiegelman BM. Molecular mechanisms of cancer development in obesity. Nat. Rev. Cancer 11, 886-895 (2011).
24. Oh SW, Park CY, Lee ES et al. Adipokines, insulin resistance, metabolic syndrome, and breast cancer recurrence: a cohort study. Breast Cancer Res. 13, 34 (2011).
25. Rivas A, Carnevale RP, Proietti CJ et al. TNF acting on TNFR1 promotes breast cancer growth via p42/P44MAPK, JNK, Akt and NF-B-dependent pathways. Experimental Cell Research 314, 509-529 (2008).
26. Burstein HJ, Prestrud AA, Seidenfeld J et al. American Society of Clinical Oncology Clinical Practice Guideline update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer. J. Clin. Oncol. 28, 3784-3796 (2010).
27. Holmes M, Chen W, Feskanich D et al. Physical activity and survival after breast cancer diagnosis. JAMA 293, 2479-2486 (2005).
28. Sternfeld B, Weltzien E, Quesenberry CP et al. Physical activity and mortality in breast cancer survivors: findings from the LACE study. Cancer Epidemiol. Biuomarkers Prev. 18, 87-95. (2009).
29. Irwin ML, McTiernan A, Manson JE et al. Physical activity and survival in postmenopausal women with breast cancer: results from the Women's Health Initiative. Cancer Prev. Res. 4, 522-529 (2011).
30. Holick CN, Newcomb PA, Trentham-Dietz A et al. Physical activity and survival after diagnosis of invasive breast cancer. Cancer Epidemiol. Biomarkers Prev. 17, 379-386 (2008).
31. Boniol M. Physical activity, hormone replacement therapy and breast cancer risk: a meta-analysis of prospective cohort studies. Presented at: The European Cancer Organisation. Glasgow, UK, 20 March 2014 (Abstract P102).
32. Rock CL, Byers TE, Colditz GA. Reducing breast cancer recurrence with weight loss, a vanguard trial: the Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) Trial. Contemp. Clin. Trials 34, 282-295 (2013).
33. Kim EH, Willet WC, Fung T. Diet quality indices and postmenopausal breast cancer survival. Nutr. Cancer 63, 381-388 (2011).
34. Villarini A, Pasanisi P, Traina A. Lifestyle and breast cancer recurrences: the DIANA-5 trial. Tumori 98, 1-18 (2012).